21
Views
13
CrossRef citations to date
0
Altmetric
Research Article

Increased Prevalence of Retrovirus Infections Among Older Women in Africa

Pages 459-466 | Published online: 08 Jul 2009

References

  • Miyazaki M. Epidemiological characteristics of human immunodeficiency virus type-2 infection in Africa. Int J STD & AIDS 1995; 6: 75–80.
  • De Cock KM, Brun-Vézinet F. Epidemiology of HIV-2 infection. AIDS 1989; 3 Suppl 1: S89–95.
  • Remy G. Image Géographic de l’infection á VIH-1 en Afrique Centrale: des discontinuités Remarquables. Ann Soc Belge Méd Trop 1993; 73: 127–42.
  • O’Keefe EA, Wood R. AIDS in Africa. Scand J Gastroenterology 1996; 31 Suppl 220: 147–52.
  • de Thé G. Épidémiologie biologique et clinique des infections onco-rétrovirales HTLV-I et II. Bull Acad Natle Méd 1991; 175: 861–70.
  • Nunn AJ, Kengeya-Kayondo JF, Malamba SS, Seely JA, Mulder DW. Risk factors for HIV-1 infection in adults in a rural Ugandan community: a population study. AIDS 1994; 8: 81–6.
  • Rwandan HIV Sero-Prevalence Study Group. Nationwide community-based serological survey of HIV-1 and other human retrovirus infections in a central African country. Lancet 1989; 1: 941–3.
  • Le Guenno B, Pison G, Enel C, Lagarde E, Seck C. HIV-2 prevalence in three rural regions of Seéneégal: low levels and heterogeneous distribution. Trans R Soc Trop Med Hyg 1992; 86: 301–2.
  • Poulsen AG, Aaby P, Frederiksen K, et al. Prevalence of and mortality from human immunodeficiency virus type 2 in Bissau, West Africa. Lancet 1987; i: 827–31.
  • Wilkins A, Ricard D, Todd J, Whittle H, Dias F, Da Silva AP. The epidemiology of HIV infection in a rural area of Guinea Bissau. AIDS 1993; 7: 1119–22.
  • Wilkins A, Hayes R, Alonso P, et al. Risk factors for HIV-2 infection in The Gambia. AIDS 1991; 5: 1127–32.
  • Santos-Ferreira MO, Cohen T, Lourenco MH, Matos Almeida MJ, Chamaret S, Montaigner L. A study of seroprevalence of HIV-1 and HIV-2 in six provinces of People’s Republic of Angola: clues to the spread of HIV infection. J AIDS 1990; 3: 780–6.
  • De Cock KM, Adjorlolo G, Ekpini E, et al. Epidemiology and transmission of HIV-2. Why is there no HIV-2 pandemic. JAMA 1993; 270: 2083–6.
  • Delaporte E, Dupont A, Peeters M, et al. Epidemiology of HTLV-I in Gabon (Western Equatorial Africa). Int J Cancer 1988; 42: 687–9.
  • Houinato D, Verdier M, Josse R, et al. Seroepidemiological study of retroviruses (HTLV-I/II, HIV-1, HIV-2) in the Department Atacora, Northern Benin. Trop Med Int Health 1996; 1: 205–9.
  • Ouattara SA, Gody M, de-Thé G. Prevalence of HTLV-1 compared to HIV-1 and HIV-2 antibodies in different groups in the Ivory Coast (West Africa). J AIDS 1989; 2: 481–5.
  • Delaporte E, Peeters M, Durand JP, et al. Seroepidemiological survey of HTLV-I infection among randomized populations of Western Central African countries. J AIDS 1989; 2: 410–13.
  • Aaby P, Ariyoshi K, Buckner M, et al. Age of wife as a major determinant of male-to-female transmission of HIV-2 infection: a community study from rural West Africa. AIDS 1996; 10: 1585–90.
  • Poulsen AG, Aaby P, Larsen O, et al. 9-year HIV-2 associated mortality in an urban community in Bissau, West Africa. Lancet 1997; 349: 911–14.
  • Larsen O, da Silva Z, Sandström A, et al. Declining HIV-2 prevalence and incidence among men in a community study from Guinea-Bissau, West Africa. AIDS 1998; 12 (13): 1707–14.
  • Melbye M, Poulsen AG, Gallo D, et al. HTLV-I infection in a population-based cohort of older persons in Guinea-Bissau, West Africa: Risk factors and impact on survival. Int J Cancer 1998; 76: 293–8.
  • Larsen O, Andersson S, da Silva Z, Hedegaard K, Sandström A, Nauclér A, Dias F, Melbye M. Prevalence of HTLV-1 infection and associated risk determinants in an urban population in Guinea-Bissau, West Africa. J AIDS & Hum Retrov. In press.
  • Benoit SN, Gershy-Damet GM, Coulibaly A, et al. Seroprevalence of HIV infection in the general population of the Côte d’Ivoire, West Africa. J AIDS 1990; 2: 1193–6.
  • Ouattara SA, Meité M, Cot MC, de-Thé G. Compared prevalence of infections by HIV-1 and HIV-2 during a 2- year period in suburban and rural areas of Ivory Coast. J AIDS 1989; 2: 94–9.
  • Biggar RJ, Neequaye JE, Neequaye AR, et al. The Prevalence of antibodies to the Human T Lymphotropic Virus (HTLV) in Ghana, West Africa. AIDS Res & HR 1993; 9: 505–11.
  • Le Hesran JY, Delaporte E, Gaudebout C, et al. Demographic factors associated with HTLV-1 infection in a Gabonese community. Int J Epidemiol 1994; 23: 812–17.
  • Jeannel D, Kourouma K, Fretz C. Regional differences in Human Retroviral Infections HIV-1, HIV-2 and HTLV-I/II in Rural Guinea (West Africa). J AIDS 1995; 8: 315–8.
  • Berkley S, Naamara W, Okware S, et al. AIDS and HIV infection in Uganda are more women infected than men? AIDS 1990; 4: 1237–42.
  • Stoneburner RL, LowBeer D, Tembo GS, Mertens TE, Asiimwe-Okiror G. Human Immunodeficiency Virus infection dynamics in East Africa deduced from surveillance data. Am J Epidemiol 1996; 144: 682–95.
  • Killewo J, Nyamuryekunge K, Sandström A, et al. Prevalence of HIV-1 infection in the Kagera region of Tanzania: a population-based study. AIDS 1990; 4: 1081–1085.
  • Mauclere P, LeHesran JY, Mahleux R, et al. Demographic, ethnic and geographic differences between human T-cell lymphotropic virus (HTLV) type I-seropositive carriers and persons with HTLV-I Gag-indeterminate Western blots in Central Africa. J Inf Dis 1997; 76: 505–9.
  • Breslow N, Day N. Statistical methods in cancer research. Volume 1. The analysis of case-control studies. Lyon: IARC, 1980.
  • Wagner HU, Kamali A, Nunn AJ, Kengeya-Kayondo JF, Mulder DW. General and HIV-1-associated morbidity in a rural Ugandan community. AIDS 1993; 7: 1461–7.
  • Wawer MJ, Serwadda D, Musgrave SD, Konde-Lule JK, Musagara M, Sewenkambo NK. Dynamics of spread of HIV-1 infection in a rural district of Uganda. Br Med J 1991; 303: 1303–6.
  • Kipp W, Kabwa P, Verbeck A, Fischer P, Eggert P, Büttner DW. Prevalence and risk factors of HIV-1 infection in three parishes in western Uganda. Trop Med Parasitol 1995; 46: 141–6.
  • Nunn AJ, Wagner HU, Okongo JM, Malamba SS, Kengeya-Kayondo JF, Mulder DW. HIV-1 infection in an Ugandan town on the trans-African highway: prevalence and risk factors. Int J STD & AIDS 1996; 7: 123–30.
  • Barongo LR, Borgdorff MW, Newell JN, et al. Intake of a cohort study of urban factory workers in Northwest Tanzania. Trop Geogr Med 1994; 46: 157–162.
  • Barongo LR, Borgdorff MW, Mosha FF, et al. The epidemiology of HIV-1 infection in urban areas, roadside settlements and rural villages in Mwanaza Region, Tanzania. AIDS 1992; 6: 1521–1528.
  • Klouman E, Masenga EJ, Klepp KI, Sam NE, Nkya W, Nkya C. HIV and reproductive tract infections in a total village population in rural Kilimanjaro, Tanzania: women at increased risk. J AIDS 1997; 14: 163–8.
  • Abdool Karim Q, Abdool Karim SS, Singh B, Short R, Ngxongo S. Seroprevalence of HIV infection in rural South Africa. AIDS 1992; 6: 1535–9.
  • Neequaye AR, Neequaye JE, Biggar RJ, Mingle JAA, Drummond J, Waters D. HIV-1 and HIV-2 in Ghana, West Africa: Community surveys compared to surveys of pregnant women. WAJM 1997; 16: 102–8.
  • Ryder RW, Ndilu M, Hassig SE, et al. Heterosexual transmission of HIV-1 among employees and their spouses at two large businesses in Zaire. AIDS 1990; 4: 725–732.
  • Mulder DW, Nunn AJ, Wagner HU, Kamali A, Kengeya- Kayondo JF. HIV-1 incidence and HIV-1 associated mortality in a rural Ugandan population cohort. AIDS 1994; 8: 87–92.
  • Norrgren H, Andersson S, Naucler A, Dias F, Johansson I, Biberfeld G. HIV-1, HTLV-I/II and Treponema pallidum infections: Incidence, prevalence, and HIV-2-associated mortality in an occupational cohort in Guinea-Bissau. J AIDS 1995; 9: 422–8.
  • Bhigjee AI, Vinsen C, Windsor IM, Gouws E, Bill PLA, Tait D. Prevalence and transmission of HTLV-I infection in Natal/KwaZulu. S Afr Med J 1993; 83: 665–7.
  • Bhigjee AI, Thaler D, Madurai S, Gouws E, Bill PLA. Seroprevalence of HTLV-I in Natal/KwaZulu. S Afr Med J 1994; 84: 368.
  • Dumas M, Houinato D, Verdier M, et al. Seroepidemiology of Human T-cell Lymphotropic Virus Type I/II in Benin (West Africa). AIDS Res & HR 1991; 7: 447–451.
  • European Study Group on Heterosexual Transmission of HIV. Comparison of female to male and male to female transmission of HIV in 563 stable couples. Br Med J 1992; 304: 809–13.
  • Stuver S, Tachibana N, Okayama A, et al. Heterosexual transmission of Human T-cell Leukemia/Lymphoma Virus Type I among married couples in Southwestern Japan: an initial report from the Miyazaki cohort study. J Inf Dis 1993; 167: 57–65.
  • Ricard D, Wilkins A, N’Gum PT, et al. The effects of HIV- 2 infection in a rural area of Guinea-Bissau. AIDS 1994; 8: 977–82.
  • Wira CR, Rossoll RM. Antigen-presenting cells in the female reproductive tract: influence of sex hormones on antigen presentation in the vagina. Immunology 1995; 84: 505–8.
  • Bjercke S, Brandtzaeg P. Glandular distribution of immunoglobulins, J chain, secretory component, and HLADR in the human endometrium throughout the menstrual cycle. Hum Reprod 1993; 9: 1425.
  • Wira CR, Sandoe CP. Specific IgA and IgG antibodies in the secretions of the female reproductive tract: effects of immunization and estradiol on expression of this response in vivo. J Immunol 1987; 138: 4159–64.
  • Parr MB, Parr EL. Langerhans cells and T lymphocyte subsets in the murine vagina and cervix. Biol Reprod 1991; 44: 491–8.
  • Edelstam GA, Lundkvist OE, Klareskog L, Karlsson-Parra A. Cyclic variation of major histocompatibility complex class II antigen expression in the human fallopian tube epithelium. Fertil Steril 1992; 57: 1225–9.
  • White D, Yeaman GR, Givan AL, Wira CR. Mucosal immunity in the human female reproductive tract: Cytotoxic T lymphocyte function in the cervix and vagina of premenopausal and postmenopausal women. Am J Reprod Immunol 1997; 37: 30–8.
  • Marx PA, Spira AI, Gettie A, et al. Progesteron implants enhance SIV vaginal transmission and early virus load. Nat Med 1996; 2: 1084–9.
  • Ho JL, He S, Hu A, Geng J, Basile FG, Almeida MG, Saito AY, Laurence J, Johnson WD Jr. Neutrophils from human immunodeficiency virus (HIV)-seronegative donors induce HIV replication from HIV-infected patients’ mononuclear cells and cell lines: an in vitro model of HIV transmission facilitated by Chlamydia trachomatis. J Exp Med 1995; 181: 1493–505.
  • Ghinsberg RC, Nitzan Y. Possible relationship between Chlamydia trachomatis and acquired immunodeficiency syndrome. Microbiologica 1992; 15: 309–12.
  • Furuta Y, Eriksson K, Svennerholm B, et al. Infection of vaginal and colonic epithelial cells by the human immunodeficiency virus type 1 is neutralised by antibodies raised against conserved epitopes in the envelope glycoprotein gp120. Proc Natl Acad Sci 1994; 91: 12559–12563.
  • Howell AL, Edkins RD, Rier SE, et al. Human immunodeficiency virus type 1 infection of cells and tissues from the upper and lower human female reproductive tract. J Virol 1997; 71: 3498–3506.
  • Spira AI, Marx PA, Patterson BK, et al. Cellular targets of infection and route of viral dissemination after an intravaginal inoculation of Simian immunodeficiency virus into Rhesus Macaques. J Exp Med 1996; 183: 215–225.
  • Hill K. The demography of menopause. Maturitas 1996; 23: 113–27.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.